Finding the Right Contract Research Organisation in Rare Disease

For sponsors, selection of the right CRO to develop their orphan drug is crucial to the delivery of a successful clinical trial. Plus, the future of the potential medicine for rare disease patients is entirely dependent upon the quality of the trials that are run. Choosing the right CRO is therefore a fundamentally important step towards success and one that should be undertaken carefully. In our latest whitepaper “Finding the Right CRO in Rare Disease”, we discuss what might impact upon this decision-making process...

What’s Inside:

Running good clinical trials within rare disease communities requires a unique skillset. There are many groups who need to collaborate to successfully run trials. In this whitepaper we discuss the role of the CRO in relation to the main groups of people who come together to deliver clinical trials.
The standard approach to building a clinical trial programme.
Key considerations to bear in mind when selecting the right CRO partner for your project.